Christen McCabe
Family · Athens, GANPI 1659983948
Payments from drug & device makers
Across 210 payments — averaging $56.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Actelion Pharmaceuticals US, Inc.$7K
- United Therapeutics Corporation$687
- Boehringer Ingelheim$664
- AstraZeneca$456
- GSK$422
- Bayer$309
- plus $2K from 20 others
What the payments were for
- Consulting fees$4,50638%
- Travel & lodging$1,99817%
- Food & beverage$5,26144%
- Education$851%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 34 | $7,363 |
| United Therapeutics Corporation | 12 | $687 |
| Boehringer Ingelheim | 23 | $664 |
| AstraZeneca(2 entities) | 21 | $456 |
| GSK | 21 | $422 |
| Bayer | 7 | $309 |
| Merck | 10 | $275 |
| Grifols USA, LLC | 11 | $236 |
| Sanofi | 7 | $230 |
| Mallinckrodt Hospital Products Inc. | 8 | $210 |
| Mylan Specialty L.p. | 13 | $202 |
| Insmed, Inc. | 8 | $138 |
| Regeneron Healthcare Solutions, Inc. | 5 | $121 |
| Baxter Healthcare | 4 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
| Viatris Specialty LLC | 3 | $54 |
| Harmony Biosciences LLC | 3 | $52 |
| Inogen, Inc. | 4 | $50 |
| Verona Pharma, Inc. | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Amgen | 2 | $32 |
| AbbVie | 2 | $30 |
| Vifor Pharma, Inc. | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Advanced Respiratory, Inc | 1 | $18 |
| Pfizer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,851 in reported general payments places this provider in the 95th percentile of 6,258 family providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 153 | $147,744 |
| Breo ElliptaFluticasone/Vilanterol | 68 | $37,033 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 41 | $34,156 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 56 | $28,611 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 27 | $16,094 |
| EliquisApixaban | 14 | $15,542 |
| Advair HfaFluticasone Propion/Salmeterol | 12 | $10,613 |
| SymbicortBudesonide/Formoterol Fumarate | 37 | $10,191 |
| Incruse ElliptaUmeclidinium Bromide | 20 | $6,623 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 27 | $4,196 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 123 | $3,380 |
| Arnuity ElliptaFluticasone Furoate | 13 | $3,136 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 15 | $2,865 |
| Montelukast Sodium | 99 | $873 |
| Ventolin HfaAlbuterol Sulfate | 13 | $728 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta, Arnuity Ellipta | $422 | $223,146310 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $456 | $44,34878 claims |
| Boehringer IngelheimStiolto Respimat | $664 | $16,09427 claims |
| PfizerEliquis | $15 | $15,54214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,258 family providers in Georgia.
Other family in Athens
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.